Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Midazolam 0.03mg/kg
Hospital Authority, Hong Kong
Child
1 trial -
Midazolam premedication
Hospital Authority, Hong Kong
Midazolam Premedication
1 trial -
Miyarisan-BM (Clostridium Butyricum Miyairi)
Hospital Authority, Hong Kong
Clostridium Butyricum Miyairi
1 trial -
Mupirocin
Hospital Authority, Hong Kong
Peritoneal Dialysis-related Infection
1 trial -
Mupirocin (drug)
Hospital Authority, Hong Kong
Biopsy Wound
1 trial -
NRT-S
The University of Hong Kong
Smoking Cessation
1 trial -
Nicotine Replacement therapy
The University of Hong Kong
Smoking
1 trial -
Norepinephrine
Shanghai Zhongshan Hospital
Gastrointestinal Disease
1 trial -
Omeprazole
Hospital Authority, Hong Kong
Gastroesophageal Reflux Disease
1 trial -
Oral fluid
Hospital Authority, Hong Kong
Osteoarthritis, Knee
1 trial -
Oral microbiota
Hospital Authority, Hong Kong
Dry Eye Syndrome
1 trial -
PG102P
Hospital Authority, Hong Kong
Uremic Pruritus
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
Physiotherapy
Chinese University of Hong Kong
Knee Arthropathy
1 trial -
Ping On Ointment
The University of Hong Kong
Temporomandibular Disorders
1 trial -
Placebo
Hospital Authority, Hong Kong
Chronic Kidney Disease
1 trial -
Placebo
Hospital Authority, Hong Kong
Hypertension in Pregnancy
1 trial -
Polyethylene glycol (PEG)
Hospital Authority, Hong Kong
Acute Kidney Injury
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Propofol
The University of Hong Kong
Anesthesia
1 trial -
Propofol
Hospital Authority, Hong Kong
Renal Cell Carcinoma
1 trial -
Prospan cough Syrup
Hong Kong Baptist University
Cough Severity
1 trial -
Protein supplementation
Hospital Authority, Hong Kong
Hip Fractures
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources